Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trace element profiles in cancer patients.

Biological trace element research·2013
Same author

Changes in zinc metabolism following exercise in human subjects.

Biological trace element research·2013
Same author

Guest editorial: Are we still on the right track?

Environmental geochemistry and health·2013
Same author

Longitudinal study comparing the dynamics of Clostridium difficile in conventional and antimicrobial free pigs at farm and slaughter.

Veterinary microbiology·2012
Same author

Arrogance.

Current surgery·2005
Same author

Editor's comment on muscle-splitting posterolateral thoracotomy: a novel technique.

Current surgery·2005
Same journal

Polycystic ovary syndrome, amenorrhea and the diagnostic role of anti-Müllerian hormone.

Minerva endocrinologica·2021
Same journal

Effects of Mediterranean diet on semen parameters in healthy young adults: a randomized controlled trial.

Minerva endocrinologica·2021
Same journal

Next generation of strain specific probiotics in diabetes treatment: the case of Prevotella copri.

Minerva endocrinologica·2020
Same journal

New perspectives in neuroendocrine neoplasms research from tumor xenografts in zebrafish embryos.

Minerva endocrinologica·2020
Same journal

Codon bias analyses on thyroid carcinoma genes.

Minerva endocrinologica·2020
Same journal

The possible role of endocrine dysfunction of adipose tissue in gestational diabetes mellitus.

Minerva endocrinologica·2020
See all related articles

Related Experiment Video

Updated: May 10, 2026

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

New technologies for treating obesity.

D M Bermudez1, W J Pories

  • 1East Carolina University, Greenville, NC, USA.

Minerva Endocrinologica
|June 5, 2013
PubMed
Summary
This summary is machine-generated.

Obesity and diabetes are growing epidemics. Innovative treatments, including bariatric surgery and emerging endoluminal therapies, offer new hope for effective obesity management beyond traditional methods.

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

Related Experiment Videos

Last Updated: May 10, 2026

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Control of Eating Behavior Using a Novel Feedback System
04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

Area of Science:

  • Obesity and metabolic disease research.

Background:

  • Obesity is a national epidemic affecting one-third of the US population.
  • Diabetes prevalence has increased by over 50%, with traditional therapies showing limited success in severely obese individuals.

Purpose of the Study:

  • To review recent advances in innovative technologies for treating obesity.
  • To explore minimally invasive procedures for a larger patient population.

Main Methods:

  • Review of current literature on obesity treatments.
  • Analysis of emerging endoluminal therapies and bariatric surgery advancements.

Main Results:

  • Bariatric surgery has significantly altered the course of severe obesity.
  • Endoluminal therapies represent a promising minimally invasive approach.

Conclusions:

  • Innovative surgical and endoluminal techniques are crucial for addressing the obesity epidemic.
  • These advanced treatments have the potential to reach a broader patient demographic.